Recalls dent Stryker Q1 earnings

Share this article:

Recalls helped sink first-quarter numbers for medical device maker Stryker. Modern Healthcare reports that the company saw earnings fall 77% for the quarter ended March 30 compared to the same period last year.

Sales, however, rose to $2.31 billion, a 5% bump compared to the same period a year ago.

As Modern Healthcare reports, $344 million in charges related to recalls of Rejuvenate and ABG II modular-neck hip stems inflicted the the 77% earnings dent. Sales rose in the company's core categories: reconstructive, medical-surgical and neurotechnology, and spine.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions